Growth PitStop®

Ready to Pitstop Your Big Project or Transformation Initiative? Speedily gather breakthrough insights and ideas from all those involved in your big project or transformation initiative, without workshops, consultants or traditional reports. growthpitstop.com/pitstop-an…

Today's real heroes aren't found in boardrooms or glossy magazines. They're at the coalface of pharmaceutical innovation – the action heroes who are making things happen. #GrowthPitstop #Pharma ow.ly/tjFa50Wjz5l

It is a time of uncertainty for leaders in the biotech and pharma industries. However, as this article shows, the industry's importance and resilience has never been clearer. #Pharma #Biotech ow.ly/cmjC50Wjz3s

Early-stage biotech is tough: Founders juggle science, strategy, and fund-raising with limited people and resources. But, don’t lose hope! That is the advice of Thanos Tsagkadouras of Galino Labs and Ray Collis of Growth Pitstop. #GrowthPitstop #Strategy ow.ly/Pwj650Wjz0l

Analysts warn of underestimating the size & sophistication of China’s pharma industry. But there is also a danger of underestimating big pharma too! In particular, the scale of its ambition and its confidence. #GrowthPitstop growthpitstop.com/2025/02/11…

It is a time of uncertainty for leaders in the biotech and pharma industries. However, as this article shows, the industry's importance and resilience has never been clearer. ow.ly/qyo550W71SB

The threat of Chinese pharma and the prospects of a US-China trade war have been stealing the headlines. The warning is that some of big pharma's blockbuster drugs could be at risk. growthpitstop.com/2025/03/26…

Welcome to the era of the pitstop – a powerful way to turbocharge your strategy execution and propel you to the finish line. ow.ly/MhPo50VuovL

Life Sciences Product & NPD teams operate in a high-stakes environment—tight deadlines, scarce resources, complex science, and stringent regulations. With so much at play, how do the best teams maximize productivity, resilience & wellbeing? ow.ly/PoBV50Vuoup

Most leaders of big projects and transformation initiatives regularly get asked about business impact and value. This is especially true when new technology and innovation is involved. Although essential, having the right answer isn't easy. ow.ly/xtEY50Vuotj

We’re gathering insights from IT leaders across Europe on their game plan for 2027. Want to join the conversation? Let's talk! #AI #Automation #QuantumComputing #CIO #CTO #BankingTech #ITLeadership #DigitalTransformation

To illuminate the power of this stakeholder insight and help you engage your stakeholders, we pulled together the above analysis of senior internal stakeholders within large organizations over the past two quarters. #Stakeholders ow.ly/FXO350Vuokw

Where to find the next 3%, 5% or more? Pitstop Analytics is the fastest way to identify real opportunities to accelerate and sustain big project momentum. ow.ly/C47B50VuonB

A recent study by Growth Pitstop reveals that the 'messiness' in large projects and transformations has increased by 11%. This challenges the traditional view of successful projects as smooth and structured. ow.ly/zhIm50VuohR

As the pressure to perform intensifies, leaders are constantly on the lookout for innovative ways to drive transformation. Welcome to the era of the pitstop – a powerful way to turbocharge your strategy execution and propel you to the finish line. ow.ly/fuP550V9a2B

Thanks to all the advance readers of Super Projects in Banking & Finance. That is 100 leaders who are helping us to put the ‘super' back in conversations about change and transformation. If you would like to contribute, we would love to hear from you. ow.ly/1ZuG50V99XF

Pharma faces pressure, but there’s reason for optimism. After years of declining R&D productivity, new tech and fresh frameworks offer hope—cutting drug development costs from billions to millions. One key factor, R&D-P, is just being recognized. ow.ly/1NNJ50V99QU

Everyone has a story—here’s ours! We joined the Tech Business Podcast with Paul Essery to explore the challenge of quantifying performance potential. Featuring insights from John O’Gorman, Ray Collis, and the GrowthPitstop team. ow.ly/ceG450V99Ns